InspireMD - OTC: NSPR
spireMD was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures.
The company has grown to include a portfolio of embolic protection systems, which it both manufactures and commercializes.
Today, InspireMD is a global company headquartered in Boston, MA. InspireMD seeks to utilize its proprietary MicroNetTM technology to make its products the industry standard for embolic protection by providing a superior solution to the key clinical issues of vascular procedures.